Thanks Pagree with that. Volatility like that is quite unusual...

First 4 Last

Share
Profile

Follow
F1Hamo

92 Posts.

11

19/03/21

17:13

Post #: 51904004
Share

Originally posted by pivalde: ↑

This huge volatility we have seen lately is bad for normal investors. It may serve some short-sellers but not the majority of investors IMO. Yesterday in premarket 20% up and in the end of the day down 6%. This is indicating that nobody knows the value of this stock, at least those who are selling them, again just IMO. Perhaps we could blame also Dr. Stamler, not telling in the investor seminar that the company owns a worldwide patent of PBT2, a molecule preventing infections to become antibiotic-resistant and able to return the ability of the antibiotics to kill again the bacteria, which cause some 700.000 deaths in the world. To keep this kind of an issue a secret in an investor presentation is wrong IMO, no excuses. Buyers and sellers need to know better what kind of value stock has. Volatility from + 20% to -6% without any news is just too much, indicating that nobody, not even the company itself knows what it has.

Expand

Thanks P
agree with that.
Volatility like that is quite unusual and no repeat that I can see. Hopefully the BOD will do something substantial with the gold mine in PBT2. Pretty quiet whatever the plans are instead of selling it especially in presentations and PR / news flow.

I suppose we just have to wait to see how this unfolds

cheers
F1

ATH Price at posting: 3.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply